BridgeBio Pharma

BBIO • NASDAQ • Stock Fundamentals

BridgeBio Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Neil Kumar, with a market cap of $13.5B.

Market Cap$13.5B

Employees556.0

CEONeil Kumar

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 19 days agoQ1 2026

Next EarningsAug 4, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about BridgeBio Pharma

BridgeBio Pharma (BBIO) has a market capitalization of $13.5B and trades on NASDAQ.

BridgeBio Pharma has approximately 556 employees.